Study of Epoetin Alfa to Treat Anemia After Kidney Transplantation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The primary purpose of this study is to determine the effect of Epoetin Alfa (Procrit) on the change in hemoglobin (red blood cell count) in anemic kidney transplant recipients. The investigators hypothesize that epoetin alfa will raise hemoglobin.
Epistemonikos ID: d932aee83e96d6136f7740c8b880017697556cb9
First added on: May 06, 2024